SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Shanghai Pharmaceuticals Holding Co Ltd (2607)
Shanghai Pharmaceuticals Holding Co Ltd stock price live, this page displays HK 2607 stock exchange data. View the 2607 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Shanghai Pharmaceuticals Holding Co Ltd real time stock price chart below.
What Is the Shanghai Pharmaceuticals Holding Co Ltd Stock Price Today?
The Shanghai Pharmaceuticals Holding Co Ltd stock price today is 12.69.
What Is the Stock Symbol for Shanghai Pharmaceuticals Holding Co Ltd?
The stock symbol for Shanghai Pharmaceuticals Holding Co Ltd is ""2607.""
What Stock Exchange Does Shanghai Pharmaceuticals Holding Co Ltd Trade On?
Shanghai Pharmaceuticals Holding Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Shanghai Pharmaceuticals Holding Co Ltd a Good Stock to Buy?
Determining whether Shanghai Pharmaceuticals Holding Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2607 quote. (ISIN: CNE1000012B3)
What Is the Shanghai Pharmaceuticals Holding Co Ltd Stock Price Today?
The Shanghai Pharmaceuticals Holding Co Ltd stock price today is 12.69.
What Is the Stock Symbol for Shanghai Pharmaceuticals Holding Co Ltd?
The stock symbol for Shanghai Pharmaceuticals Holding Co Ltd is ""2607.""
What Stock Exchange Does Shanghai Pharmaceuticals Holding Co Ltd Trade On?
Shanghai Pharmaceuticals Holding Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Shanghai Pharmaceuticals Holding Co Ltd a Good Stock to Buy?
Determining whether Shanghai Pharmaceuticals Holding Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2607 quote. (ISIN: CNE1000012B3)
12.69
+0.11(+0.87%)
Delayed Data·
Fair Value
An estimate of a Shanghai Pharma Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.58
12.72
52 wk Range
10.04
14.70
2607 Scorecard
Full Analysis
Trading at a low Price / Book multiple
2607 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Shanghai Pharma Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.5812.72
52 wk Range
10.0414.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2607 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Shanghai Pharma Holding's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
13.45
Upside
+5.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Shanghai Pharmaceuticals Holding Co Ltd Company Profile
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
Compare 2607 to Peers and Sector
Metrics to compare | 2607 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2607PeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.6x | 13.8x | −0.5x | |
PEG Ratio | 1.05 | −0.37 | 0.00 | |
Price/Book | 0.9x | 0.8x | 2.6x | |
Price / LTM Sales | 0.2x | 0.3x | 3.3x | |
Upside (Analyst Target) | 8.5% | 14.5% | 41.6% | |
Fair Value Upside | Unlock | 11.2% | 5.9% | Unlock |
Analyst Ratings
8 Buy
3 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13.45
(+5.99% Upside)
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
0.36 / 0.421
Revenue / Forecast
70.76B / 74.29B
People Also Watch
FAQ
What Stock Exchange Does Shanghai Pharma Holding Trade On?
Shanghai Pharma Holding is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Shanghai Pharma Holding?
The stock symbol for Shanghai Pharma Holding is "2607."
What Is the Shanghai Pharma Holding Market Cap?
As of today, Shanghai Pharma Holding market cap is 77.01B.
What Is Shanghai Pharma Holding's Earnings Per Share (TTM)?
The Shanghai Pharma Holding EPS (TTM) is 1.17.
When Is the Next Shanghai Pharma Holding Earnings Date?
Shanghai Pharma Holding will release its next earnings report on 23 Oct 2025.
From a Technical Analysis Perspective, Is 2607 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Shanghai Pharma Holding Stock Split?
Shanghai Pharma Holding has split 0 times.
How Many Employees Does Shanghai Pharma Holding Have?
Shanghai Pharma Holding has 49402 employees.
What is the current trading status of Shanghai Pharma Holding (2607)?
As of 13 Aug 2025, Shanghai Pharma Holding (2607) is trading at a price of 12.69, with a previous close of 12.58. The stock has fluctuated within a day range of 12.58 to 12.72, while its 52-week range spans from 10.04 to 14.70.
What Is Shanghai Pharma Holding (2607) Price Target According to Analysts?
The average 12-month price target for Shanghai Pharma Holding is HKD13.4495, with a high estimate of HKD18 and a low estimate of HKD10.29. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +5.99% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.